
Digital Breast Tomosynthesis and Contrast Enhanced Mammography - Case 10 - USA
Invasive ductal carcinoma: TiCEM was useful to diagnose an initial false positive (FP) case as a true negative (TN), and an initial false negative (FN) case as a true positive (TP) result
The herein illustrated statements made by Siemens’ customers and physicians are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.
The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist there can be no guarantee that other customers will achieve the same results.
Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens organization for further details.
We moved to case 10. It was a 49 year old lady with no symptoms, routinely mammography and unconventional mammography. We detected nothing on the MLO views and in the craniocardial views we detected something suspicious. In the inner quadrants we performed turmoil and well, it was not so suspicious. Could be normal fibroglandular tissue. We have a still a small doubt about that. But oh, there was something just in the opposite quadrants. In the outer quadrants there was an irregular speculated mass, so we were not looking at the correct quadrant. When we moved to the contrast enhanced mammography, we see an enhancement in the outer quadrants. This was an invasive ductal cancer and nothing suspicious in the inner quadrants. And here you can see the correlation with MRI. Only one single lesion and final result was a 10mm invasive Dr. cancer luminal aid subtype. So the take home messages for this case are that Tyson was very useful to diagnose an initial false positive case as a true negative and an initial false negative case as a true result.
13 cima Case 10 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Clínica Universidad de Navarra Universidad Pamplona, Spain de Navarra ENSIS Administrator SIEMENS R_case_10, Pina * 8/6/2018 O Reading_2018 Series MG Breast Add Study MG Reading MG, 8/6/2018 Unknown study description First Step Previous Next Previous ReportFlow step [CTRL B] Reset TOMO LCC Findings CC Tools INSIGHT 2D RCC TOMO RCC 9:10 AM Prof. Pina CEM information year-old lady Asymptomatic Timepoints MG Clinical 49-year-old lady Layout ical Technical Image to Hide Lines LOCK Server: VIASRV Quadrant IN LMLO Next ReportFlow step [CTRL F] Text LCC Lock OMO RCC Ultrasound B RES-B P 44mm PRC 12/2/1 PRS 4 PST 2 DR. PINA LA523 D1 1.03 Cm D1 1.03 cm PST MR DBT hology nm invasive tal carcinoma ninal A type 67 10%, ogen 98%) tinel node Pathology 10mm invasive ductal carcinoma Luminal A subtype (Ki 67 10%, Estrogen 98%) Negative sentinel node rnings M was useful al false tive (FP) as a negative (TN), an initial false ative (FN) positive (TP) Learnings TiCEM was useful to diagnose an initial false case as a true negative (TN), and an initial false negative (FN) true positive (TP) result Siemens Healthineers AG, 2024 Please note: This learning material is for training purposes only. Please note: Some functions shown in this material are optional and might not be part of your system. Certain products, product related claims or functionalities (hereinafter collectively "Functionality") may not (yet) be commercially available in your country. Due to regulatory requirements, the availability of said Functionalities in any specific country is not guaranteed. Please contact your local Siemens Healthineers sales representative for the most current information. The reproduction, transmission or distribution of this training or its contents is not permitted without express written authority. Offenders will be liable for damages. The statements by customers of Siemens Healthineers described herein are based on results that were achieved in the customer's unique setting. Because there is no "typical" hospital or laboratory and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results. The speakers and/or their employer receive financial support from Siemens Healthineers for collaborations. All rights, including rights created by patent grant or registration of a utility model or design, are reserved. He Healthineers
- MG
- breast
- contrast media
- contrast
- enhanced
- mammo